O-GlcNAc Modification and Its Role in Diabetic Retinopathy
Open Access
- 5 August 2022
- journal article
- review article
- Published by MDPI AG in Metabolites
- Vol. 12 (8) , 725
Abstract
Diabetic retinopathy (DR) is a leading complication in type 1 and type 2 diabetes and has emerged as a significant health problem. Currently, there are no effective therapeutic strategies owing to its inconspicuous early lesions and complex pathological mechanisms. Therefore, the mechanism of molecular pathogenesis requires further elucidation to identify potential targets that can aid in the prevention of DR. As a type of protein translational modification, O-linked β-N-acetylglucosamine (O-GlcNAc) modification is involved in many diseases, and increasing evidence suggests that dysregulated O-GlcNAc modification is associated with DR. The present review discusses O-GlcNAc modification and its molecular mechanisms involved in DR. O-GlcNAc modification might represent a novel alternative therapeutic target for DR in the future.Keywords
Funding Information
- Natural Science Foundation of Liaoning Province (No. 2020-BS-189, LQ2017005)
- Basic Scientific Research Projects of Liaoning provincial education department (No. 2020-BS-189, LQ2017005)
- Liaoning Provincial Program for Top Discipline of Basic Medical Sciences. (No. 2020-BS-189, LQ2017005)
This publication has 116 references indexed in Scilit:
- Intravitreal steroids for macular edema in diabetesCochrane Database of Systematic Reviews, 2020
- Investigating the Effects of O-GlcNAc Modifications in Parkinson’s Disease Using Semisynthetic α-Synuclein2020
- Pericyte Secretome2018
- Diverse metabolic effects of O-GlcNAcylation in the pancreas but limited effects in insulin-sensitive organs in miceDiabetologia, 2017
- Activation of the TXNIP/NLRP3 inflammasome pathway contributes to inflammation in diabetic retinopathy: a novel inhibitory effect of minocyclineInflammation Research, 2016
- Polymodal Sensory Integration in Retinal Ganglion Cells2015
- A decreased ratio between serum levels of the antagonistic angiopoietins 1 and 2 indicates tumour progression of malignant melanomaArchives of Dermatological Research, 2012
- Genome‐scale identification of UDP‐GlcNAc‐dependent pathwaysProteomics, 2008
- Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retinaDiabetologia, 2003
- Identification of GFAT1-L, a novel splice variant of human glutamine: fructose-6-phosphate amidotransferase (GFAT1) that is expressed abundantly in skeletal muscleJournal of Human Genetics, 2001